Phase 4 Edema Secondary Clinical Trials
3 recruitingPhase 4
What is a Phase 4 trial?
Phase 4 trials, also called post-marketing studies, are conducted after a treatment has been approved and is available to the public. They monitor long-term effectiveness and safety in a broader population.
Showing 1–3 of 3 trials
Recruiting
Phase 4
Intravitreal Aflibercept for the Treatment of Treatment Resistant Macular Oedema secondary to Retinal Vein Occlusions
macular oedema secondary to retinal vein occlusion
A/Prof Andrew Chang50 enrolled1 locationACTRN12617001487303
Completed
Phase 4
The combination treatment of laser bypass (chorioretinal venous anastomosis) and Lucentis for the treatment of macula oedema (swelling at the back of the eye) that has occurred as a result of a central retinal vein occlusion, compared to the published results of Lucentis treatment only.
Maucula oedema secondary to central retinal vein occlusion.
Lions Eye Institute100 enrolled1 locationACTRN12615001094561
Completed
Phase 4
A comparison of the number of Lucentis injections(eye injections) required for patients who receive a combination treatment of laser bypass (chorioretinal venous anastomosis) and Lucentis or sham laser bypass and Lucentis for the treatment of macular oedema (swelling at the back of the eye) that has occurred as a result of a central retinal vein occlusion.
Macular oedema secondary to central retinal vein occlusion.
Lions Eye Institute58 enrolled1 locationACTRN12612000004864